Navigation Links
R-Tech Ueno Starts Early Phase II Clinical Trial for RK-023
Date:10/6/2009

s release related July 16, 2009 for more information about the Phase I clinical trial.
  • In a double-blind test, for the purpose of conducting the clinical trial in a completely objective manner, the physicians performing the trial as well as the patients participating in the trial do not know if the substance administered to each individual is the drug being tested or the placebo.
  • The placebo is a substance that does not include the drug being tested (RK-023 in this case).
  • About R-Tech Ueno, Ltd.

    R-Tech Ueno was established in September 1989 for the purpose of marketing and R&D of drugs. Under the leadership of the CEO, also a medical doctor, the company is developing new drugs on the theme "Physician-Oriented New Drug Innovation," targeting ophthalmologic and dermatologic diseases that previously had no effective therapeutic agent. The company's main product Rescula(R) eyedrop 0.12% is a therapeutic drug for glaucoma and ocular hypertension and has been marketed in Japan since 1994. R-Tech Ueno was the first in the world to take advantage of the substance "prostone" in the development of Rescula(R). Prostone was discovered in 1980 by Dr. Ryuji Ueno, the founder of the company. Rescula(R) eyedrop 0.12% that causes less topical and systemic adverse reactions demonstrates steady ocular pressure-decreasing action by twice-a-day instillation. Such excellent therapeutic effects are realized through its optic nerve protection and ocular blood flow-increasing mechanism.

        Stock Code: No.4573, Osaka Securities Exchange; Hercules
        Head Office: 1-1-7 Uchisaiwai-cho, Chiyoda-ku, Tokyo
        Representative Director & President: Yukihiko Mashima
    
    
        Contact:
        Koji Nakamura,
        Business Management Department
        R-Tech Ueno, Ltd.
        Tel: +81-3-3596-8011
        e-mail: koji.nakamura@rtueno.co.jp
        URL: '/>"/>
    SOURCE R-Tech Ueno, Ltd.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
    2. R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021
    3. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
    4. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
    5. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
    6. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
    7. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
    8. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
    9. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
    10. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
    11. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/74vlb2/electro_surgical ) ... Surgical Market" report to their offering. ... achieve a CAGR of 7% for the forecast ... patients as well as surgeons such as fast ... bleeding control and improved accuracy are some of ...
    (Date:5/5/2015)... Calif. and ST. LOUIS ... high blood pressure or high cholesterol may achieve better ... performance-based networks, according to early results of a unique ... (NASDAQ: ESRX ). "Pharmacists are one ... their frequent interactions with our members presents enormous opportunities ...
    (Date:5/5/2015)... May 5, 2015 Big Market Research presents ... Europe , ( France , ... Spain , UK) and Japan . Current ... The report provides the 5-year test volume and sales forecasts by ... Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT ...
    Breaking Medicine Technology:Global Electro Surgical Market 2015 2SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 2SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 3SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 42015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3
    (Date:5/5/2015)... Fla. (PRWEB) May 05, 2015 Baptist ... the Commission on Cancer (CoC) of the American College ... cancer program must meet more than 30 Commission on ... through a survey process, and maintain levels of excellence ... , When patients choose to seek care locally at ...
    (Date:5/5/2015)... Atlanta, Georgia (PRWEB) May 05, 2015 ... Software of Victoria BC announced the Skedans Sensor ... The platform, for mobile and web app developers, provides ... from airborne and mobile sensors. , The Skedans Sensor ... at the intersection of the Internet of Things, Web ...
    (Date:5/5/2015)... May 05, 2015 MAP Health Management, ... revenue cycle management for addiction treatment facilities, announced today ... President of Business Development. Mr. Mooney, who has more ... field, will be responsible for developing new strategic partnerships ... MAP’s core products and new initiatives. , Prior to ...
    (Date:5/5/2015)... (PRWEB) May 05, 2015 Okyanos, the ... Lifestyle Report today. The study was conducted to determine ... as osteoarthritis and sports-related injuries have had ... stiffness was the most prevalent symptom reported at 73%, ... as walking, standing and bending over. Over half of ...
    (Date:5/5/2015)... On April 8th, 2015, at the ... Recovery sponsored Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, a daylong ... sustainable product placement in TV and film. , ... of ecologically sound and socially conscious products and services, ... that makes appearances at various awards ceremonies and festivals ...
    Breaking Medicine News(10 mins):Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2
    ... , , BANNOCKBURN, Ill., July 14 ... are afoot. The season is also notoriously a time when people want ... daunting, especially with so many people pressed for time and money. ... summer that,s accessible, affordable and can accommodate even the busiest of schedules ...
    ... , , , ... (NYSE: WPI ), a leading specialty pharmaceutical company, ... the U.S. Food and Drug Administration (FDA) on its New ... injectable suspension), a 24-week formulation of TRELSTAR(R) for the palliative ...
    ... ... services to hospital , ... TX (Vocus) July 14, 2009 -- Broadlane announced today that Temple University Health ... chain management and procurement services in a three-year exclusive agreement to help manage its ...
    ... , , , NEW YORK, ... beat its original goal for first time fundraising event -- the Hudson Valley ... To date, it has raised more than $280,000. The objective has ... According to Anthony Mann, founder of the bike ride and President-Elect of ...
    ... SHANGHAI, July 14 Fi Asia-China, China,s premiere event for professionals ... China on 23-25 June, 2009. Building on the successful launch of ... shows ran alongside Fi Asia-China and proved to be the major draw ... , Ingredients for Healthy Living , ...
    ... , DEERFIELD BEACH, Fla., July 14 A ... suggests drinking fat-free milk in the morning may be better than drinking ... However, the study only looks at feeling full, not weight loss ... are intolerant to proteins in milk, or lactose intolerant, which can cause ...
    Cached Medicine News:Health News:Looking to Shape Up for Summer? The Solution May Be the Steps You're Already Taking 2Health News:Looking to Shape Up for Summer? The Solution May Be the Steps You're Already Taking 3Health News:Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA 2Health News:Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA 3Health News:Temple University Health System to Improve Supply Chain with Broadlane 2Health News:Temple University Health System to Improve Supply Chain with Broadlane 3Health News:Temple University Health System to Improve Supply Chain with Broadlane 4Health News:Temple University Health System to Improve Supply Chain with Broadlane 5Health News:Temple University Health System to Improve Supply Chain with Broadlane 6Health News:JBFCS Surpasses Fundraising Goal For Hudson Valley Bike Ride Despite Difficult Financial Times 2Health News:The Power of Functional Foods is the Key to Fi Asia-China's Success 2Health News:The Power of Functional Foods is the Key to Fi Asia-China's Success 3Health News:Milk: Does It Do A Body Good? 2Health News:Milk: Does It Do A Body Good? 3
    Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
    For the quantitative determination of direct bilirubin in human serum. Linearity: 20 mg/dl...
    For the quantitative determination of direct & total bilirubin in serum. Modified Malloy-Evelyn Diazotization Method. Endpoint Reaction Product measured at 540 nm. Linearity: 20 mg/dl...
    ... spectrophotometer designed specifically to run 24 hours ... rugged hardware, proven optical performance and a ... traditional spectrophotometry to obtain results quickly, accurately ... up to eight, 1 cm Biocell cuvettes ...
    Medicine Products: